Morphic Therapeutic (MORF)
(80% Positive) Morphic Holding, Inc. (MORF) Provides Update on grows for its mission to create integrin medicines
(80% Positive) Morphic Holding, Inc. (MORF) Provides Update on grows for its mission to create integrin medicines
📋 Morphic Holding, Inc. (MORF) - Clinical Trial Update
Filing Date: 2022-05-12
Accepted: 2022-05-12 08:46:32
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
Structured Data: